FINWIRES · TerminalLIVE
FINWIRES

Oil Edges Down on Hopes U.S.-Iran Talks Will Lead to a Deal to End the War

By

Oil prices edged lower early on Tuesday amid an uncertain outlook for talks between Iran and the United States.

West Texas Intermediate crude oil for May delivery was last seen down US$0.29 to US$89.32 per barrel, while June Brent oil was down US$0.13 to US$95.35.

The drop comes amid expectations that talks between the two countries will reach a deal to end hostilities as a two-week ceasefire agreement is set to expire tomorrow. However Iran has not publicly confirmed it will send negotiators to Pakistan to meet with the United States, though the Wall Street Journal reports Iran has told mediators it will send a team to the talks.

Prices surged on Monday as Iran on Friday briefly opened and then again closed the Strait of Hormuz as the United States continued to block Iranian ports and disabled and boarded an Iranian cargo ship. The closure of the Strait is blocking oil exports from the Persian Gulf nations that supplied 20% of daily oil demand.

"Potential talks with the US in Islamabad ahead of the ceasefire's expiry on Wednesday follows a weekend marked by renewed tensions and conflicting signals, leaving the Strait of Hormuz effectively closed for now. The limited number of vessels managing to transit has done little to ease the ongoing tightening of the global energy market, which is increasingly short of prompt supplies - supporting elevated prices across diesel, jet fuel, fertilisers, and other key commodities," Saxo Bank noted.

The closure of the Strait has forced up spot prices for oil as Asian nations fight for immediately available supply while raising concerns high oil prices, as well as the price of refined products, LNG and other commodities supplied by Persian Gulf countries, will hike inflation and force higher interest rates.

"Financial markets are betting that a US/Iranian resolution will save us in time from violent shortages down the road. But every day that the (Strait) remains closed is bringing us closer to a potentially very painful point of shortages and much higher prices," Bjarne Schieldrop, chief analyst commodities at SEB Research, wrote.

Related Articles

Sectors

Sector Update: Energy Stocks Mixed Late Afternoon

Energy stocks were mixed late Monday afternoon with the NYSE Energy Sector Index rising 0.2% and the State Street Energy Select Sector SPDR ETF (XLE) shedding 0.1%.The Philadelphia Oil Service Sector Index fell 0.8%, and the Dow Jones US Utilities Index fell 0.6%.West Texas Intermediate crude oil jumped 5.9% to $88.79 a barrel, and global benchmark Brent rose 5.3% to $95.19 a barrel. Henry Hub natural gas futures increased 0.3% to $2.68 per 1 million BTU.In corporate news, Devon Energy (DVN) shares rose 1.3% after Tudor Pickering Holt upgraded the stock to buy from hold with a $63 price target.USA Rare Earth (USAR) agreed to acquire Brazilian rare earths miner Serra Verde in a cash-and-stock deal with an equity value of about $2.8 billion. USA Rare Earth shares jumped 13%.Eni (E) and Repsol reached a deal with the Venezuelan government to begin exporting natural gas from the country's Perla field in the Gulf of Venezuela, shipping the fuel in the form of liquefied natural gas from a floating terminal, Bloomberg reported. Separately, Eni made a gas discovery in the Kutei Basin off the coast of Indonesia. Eni shares rose 0.4%.Sable Offshore (SOC) shares climbed 3.4% after it said capital expenditures across its assets are expected to be around $180 million from April through December.

$DVN$E$SOC$USAR
Sectors

Sector Update: Financial Stocks Mixed Late Afternoon

Financial stocks were mixed in late Monday afternoon trading, with the NYSE Financial Index decreasing 0.1% and the State Street Financial Select Sector SPDR ETF (XLF) adding 0.3%.The Philadelphia Housing Index was rising 0.7%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) was up 0.2%.Bitcoin (BTC-USD) was climbing 3.3% to $76,265, and the yield for 10-year US Treasuries was slightly higher at 4.25%.In corporate news, Intercontinental Exchange-backed (ICE) predictions site Polymarket is in talks to raise about $400 million at a valuation of roughly $15 billion, including the new proceeds, The Information reported. Intercontinental Exchange shares were down 0.5%.Sila Realty Trust (SILA) agreed to be acquired and taken private by affiliates of Blue Owl Capital's (OWL) real estate unit in an all-cash deal worth roughly $2.4 billion. Sila shares jumped 19%, and Blue Owl was up 0.5%.Apollo Global Management (APO) has agreed to invest $1.25 billion in convertible preferred equity in McKesson's (MCK) Medical-Surgical Solutions business, acquiring about a 13% minority stake as part of the unit's planned separation, McKesson said Monday. Apollo shares rose nearly 2%.Blackstone-backed (BX) Jersey Mike's Subs said Monday that it has confidentially filed a draft registration statement with the US Securities and Exchange Commission for a proposed initial public offering. Blackstone shares were decreasing 0.2%.

$APO$BX$ICE$OWL$SILA
Sectors

Sector Update: Health Care Stocks Fall Late Afternoon

Health care stocks declined late Monday afternoon, with the NYSE Health Care Index down 1.1% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 1%.The iShares Biotechnology ETF (IBB) decreased 0.4%.In corporate news, Tvardi Therapeutics (TVRD) shares fell 4.1% after Barclays downgraded the company's stock to underweight from equalweight and adjusted the price target to $3 from $4.Eli Lilly (LLY) has agreed to buy clinical-stage biotechnology firm Kelonia Therapeutics for up to $7 billion, as the drugmaker looks to bolster its cancer treatment portfolio. Lilly shares were easing 0.6%.Compass Pathways (CMPS), GH Research (GHRS), and other psychedelic companies' shares were up on Monday, after US President Donald Trump signed an executive order Saturday to expedite access to treatments for patients with serious mental illness. Compass shares surged 42%, and GH Research jumped 17%.Nektar Therapeutics (NKTR) shares climbed 18% after it said Monday that data from a 16-week extension period of its phase 2b study of rezpegaldesleukin showed a "deepening of response" in people with severe-to-very-severe alopecia areata.

$CMPS$GHRS$LLY$NKTR$TVRD